RAPP position history
The shares of Rapport Therapeutics (RAPP) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 75,000 shares, $2.2M, 0.55% of portfolio, New
- 2025 Q4: 75,000 shares, $2.3M, 0.53% of portfolio
- 2026 Q1: 75,000 shares, $2.3M, 0.53% of portfolio
- 2026 Q2: 75,000 shares, $3.1M, 0.60% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|